Nirala BK, Yamamichi T, Yustein JT. Deciphering the signaling mechanisms of osteosarcoma tumorigenesis. Int J Mol Sci 2023;24(14).

Wang S, Ren Q, Li G, Zhao X, Zhao X, Zhang Z. The targeted therapies for osteosarcoma via six major pathways. Curr Mol Pharmacol. 2024;17(1):e210823220109.

PubMed  Google Scholar 

Bian J, Liu Y, Zhao X, Meng C, Zhang Y, Duan Y, Wang G. Research progress in the mechanism and treatment of osteosarcoma. Chin Med J. 2023;136(20):2412–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Panez-Toro I, Munoz-Garcia J, Vargas-Franco JW, Renodon-Corniere A, Heymann MF, Lezot F, Heymann D. Advances in osteosarcoma. Curr Osteoporos Rep. 2023;21(4):330–43.

Article  PubMed  PubMed Central  Google Scholar 

Tan L, Wang Y, Hu X, Du G, Tang X, Min L. Advances of osteosarcoma models for drug discovery and precision medicine. Biomolecules 2023;13(9).

Ma Y, Cong L, Shen W, Yang C, Ye K. Ferroptosis defense mechanisms: the future and hope for treating osteosarcoma. Cell Biochem Funct. 2024;42(4):e4080.

Article  CAS  PubMed  Google Scholar 

Chen H, Hu J, Xiong X, Chen H, Lin B, Chen Y, Li Y, Cheng D, Li Z. AURKA Inhibition induces ewing’s sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis. Cell Death Dis. 2024;15(1):99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen H, Hu J, Xiong X, Chen H, Liao Q, Lin B, Chen Y, Peng Y, Li Y, Cheng D, et al. SETD8 inhibits apoptosis and ferroptosis of ewing’s sarcoma through YBX1/RAC3 axis. Cell Death Dis. 2024;15(7):494.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zou Q, Zhou X, Lai J, Zhou H, Su J, Zhang Z, Zhuang X, Liu L, Yuan R, Li S, et al. Targeting p62 by Sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment. Redox Biol. 2025;79:103460.

Article  CAS  PubMed  Google Scholar 

Zhang F, Wan J, Zhong J, Mo J. ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis. BMC Cancer. 2024;24(1):1075.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Guo J, Jia R. N6-Methyladenosine methyltransferase component KIAA1429 is a potential target of cancer therapy. Biomolecules 2024;14(10).

Ren M, Pan H, Zhou X, Yu M, Ji F. KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m(6)A-YTHDF2-dependent manner. J Transl Med. 2024;22(1):584.

Article  CAS  Google Scholar 

Wu L, Zhou Y, Fu J. KIAA1429 promotes nasopharyngeal carcinoma progression by mediating m6A modification of PTGS2. Crit Rev Immunol. 2023;43(4):15–27.

Article  CAS  PubMed  Google Scholar 

Tan K, Lu W, Chen F, Shi H, Ma Y, Chen Z, Wu W, Lv Z, Mo J. CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in ewing sarcoma. J Exp Clin Cancer Res CR. 2023;42(1):250.

Article  CAS  PubMed Central  Google Scholar 

Sun Y, Lei YW, Zeng JX, Zhong LY, Liu JW, Man YN, He ML. Clinical significance and potential mechanisms of the RNA methyltransferase KIAA1429 in osteosarcoma. J Cancer. 2024;15(1):126–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Rao B, Yang J, Liu L, Huang M, Liu X, Cui G, Li C, Han Q, Yang H, et al. Dysregulated m6A-Related regulators are associated with tumor metastasis and poor prognosis in osteosarcoma. Front Oncol. 2020;10:769.

Article  PubMed  PubMed Central  Google Scholar 

Luo J, Wang X, Chen Z, Zhou H, Xiao Y. The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma. J Bone Oncol. 2023;39:100471.

Article  PubMed  PubMed Central  Google Scholar 

Schmidlin CJ, Shakya A, Dodson M, Chapman E, Zhang DD. The intricacies of NRF2 regulation in cancer. Sem Cancer Biol. 2021;76:110–9.

Article  CAS  Google Scholar 

Roh JL. Nrf2 targeting in overcoming ferroptosis evasion in head and neck cancer. Biochem Biophys Res Commun. 2023;671:225–8.

Article  CAS  PubMed  Google Scholar 

Liu Y, Lang F, Yang C. NRF2 in human neoplasm: cancer biology and potential therapeutic target. Pharmacol Ther. 2021;217:107664.

Article  CAS  PubMed  Google Scholar 

Yan R, Lin B, Jin W, Tang L, Hu S, Cai R. NRF2, a superstar of ferroptosis. Antioxid (Basel Switz) 2023, 12(9).

Zhang B, Hou Q, Zhang X, Ma Y, Yuan J, Li S, Zhao X, Sun L, Wang H, Zheng H. Anesthetic Propofol inhibits ferroptosis and aggravates distant cancer metastasis via Nrf2 upregulation. Free Radic Biol Med. 2023;195:298–308.

Article  CAS  PubMed  Google Scholar 

Zhang S, Huang J, Lan Z, Xiao Y, Liao Y, Basnet S, Huang P, Li Y, Yan J, Sheng Y, et al. CPEB1 controls NRF2 proteostasis and ferroptosis susceptibility in pancreatic cancer. Int J Biol Sci. 2024;20(8):3156–72.

Article  PubMed  PubMed Central  Google Scholar 

Wang K, Wang G, Li G, Zhang W, Wang Y, Lin X, Han C, Chen H, Shi L, Reheman A, et al. m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation. Apoptosis Int J Program Cell Death. 2023;28(3–4):627–38.

Article  Google Scholar 

Probst BL, Trevino I, McCauley L, Bumeister R, Dulubova I, Wigley WC, Ferguson DA. RTA 408, A novel synthetic triterpenoid with broad anticancer and Anti-Inflammatory activity. PLoS ONE. 2015;10(4):e0122942.

Article  PubMed  PubMed Central  Google Scholar 

Sun S, Guo C, Gao T, Ma D, Su X, Pang Q, Zhang R. Hypoxia enhances glioma resistance to sulfasalazine-induced ferroptosis by upregulating SLC7A11 via PI3K/AKT/HIF-1α Axis. Oxid Med Cell Longev 2022;2022:7862430.

Su J, Liu F, Xia M, Xu Y, Li X, Kang J, Li Y, Sun L. p62 participates in the Inhibition of NF-kappaB signaling and apoptosis induced by sulfasalazine in human glioma U251 cells. Oncol Rep. 2015;34(1):235–43.

Article  CAS  PubMed  Google Scholar 

Anandhan A, Dodson M, Shakya A, Chen J, Liu P, Wei Y, Tan H, Wang Q, Jiang Z, Yang K, et al. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci Adv. 2023;9(5):eade9585.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng XJ, Chen WL, Yi J, Li W, Liu JY, Fu WQ, Ren LW, Li S, Ge BB, Yang YH, et al. Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis. Acta Pharmacol Sin. 2022;43(11):2977–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan Z, Wang X, Qin B, Hu R, Miao R, Zhou Y, Wang L, Liu T. Targeting NQO1 induces ferroptosis and triggers anti-tumor immunity in immunotherapy-resistant KEAP1-deficient cancers. Drug Resist Updat. 2024;77:101160.

Article  CAS  PubMed  Google Scholar 

Kathiresan N, Selvaraj C, Pandian S, Subbaraj GK, Alothaim AS, Safi SZ, Kulathaivel L. Proteomics and genomics insights on malignant osteosarcoma. Adv Prot Chem Struct Biol 2024;138:275–300.

Article  CAS  Google Scholar 

Shanmugavadivu A, Lekhavadhani S, Miranda PJ, Selvamurugan N. Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment. Biomed Mater (Bristol Engl) 2024;19(2).

Qin S, Wang Y, Ma C, Lv Q. Competitive endogenous network of circrna, lncrna, and MiRNA in osteosarcoma chemoresistance. Eur J Med Res. 2023;28(1):354.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Li MJ, Xia L, Zhang H. The biological function of m6A methyltransferase KIAA1429 and its role in human disease. PeerJ. 2022;10:e14334.

Article  PubMed  PubMed Central  Google Scholar 

Lan T, Li H, Zhang D, Xu L, Liu H, Hao X, Yan X, Liao H, Chen X, Xie K, et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol Cancer. 2019;18(1):186.

Article  CAS  PubMed  PubMed Central